Literature DB >> 7646476

Residues in the synuclein consensus motif of the alpha-synuclein fragment, NAC, participate in transglutaminase-catalysed cross-linking to Alzheimer-disease amyloid beta A4 peptide.

P H Jensen1, E S Sørensen, T E Petersen, J Gliemann, L K Rasmussen.   

Abstract

The widespread deposition of amyloid plaques is one of the hallmarks of Alzheimer disease (AD). A recently described component of amyloid plaques is the 35-residue peptide, non-A beta component of AD amyloid, which is derived from a larger intracellular neuronal constituent, alpha-synuclein. We demonstrate that transglutaminase catalyses the formation of the covalent non-A beta component of AD amyloid polymers in vitro as well as polymers with beta-amyloid peptide, the major constituent of AD plaques. The transglutaminase-reactive amino acid residues in the non-A beta component of AD amyloid were identified as Gln79 and Lys80. Lys80 is localized in a consensus motif Lys-Thr-Lys-Glu-Gly-Val, which is conserved in the synuclein gene family. Thus transglutaminase might be involved in the formation of insoluble amyloid deposits and participate in the modification of other members of the synuclein family.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7646476      PMCID: PMC1135858          DOI: 10.1042/bj3100091

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  25 in total

1.  The rat brain synucleins; family of proteins transiently associated with neuronal membrane.

Authors:  L Maroteaux; R H Scheller
Journal:  Brain Res Mol Brain Res       Date:  1991-10

2.  Sorting-out of acceptor-donor relationships in the transglutaminase-catalyzed cross-linking of crystallins by the enzyme-directed labeling of potential sites.

Authors:  L Lorand; K N Parameswaran; P T Velasco
Journal:  Proc Natl Acad Sci U S A       Date:  1991-01-01       Impact factor: 11.205

Review 3.  Synuclein proteins and Alzheimer's disease.

Authors:  A J Brookes; D St Clair
Journal:  Trends Neurosci       Date:  1994-10       Impact factor: 13.837

4.  Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa.

Authors:  H Schägger; G von Jagow
Journal:  Anal Biochem       Date:  1987-11-01       Impact factor: 3.365

5.  Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal.

Authors:  L Maroteaux; J T Campanelli; R H Scheller
Journal:  J Neurosci       Date:  1988-08       Impact factor: 6.167

6.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 7.  Transglutaminases.

Authors:  L Lorand; S M Conrad
Journal:  Mol Cell Biochem       Date:  1984       Impact factor: 3.396

8.  Protein cross-linking by transglutaminase induced in long-term potentiation in the Ca1 region of hippocampal slices.

Authors:  P Friedrich; L Fesus; E Tarcsa; G Czéh
Journal:  Neuroscience       Date:  1991       Impact factor: 3.590

9.  Brain transglutaminase: in vitro crosslinking of human neurofilament proteins into insoluble polymers.

Authors:  D J Selkoe; C Abraham; Y Ihara
Journal:  Proc Natl Acad Sci U S A       Date:  1982-10       Impact factor: 11.205

10.  Requirement for transglutaminase in the activation of latent transforming growth factor-beta in bovine endothelial cells.

Authors:  S Kojima; K Nara; D B Rifkin
Journal:  J Cell Biol       Date:  1993-04       Impact factor: 10.539

View more
  22 in total

1.  Binding of Abeta to alpha- and beta-synucleins: identification of segments in alpha-synuclein/NAC precursor that bind Abeta and NAC.

Authors:  P H Jensen; P Hojrup; H Hager; M S Nielsen; L Jacobsen; O F Olesen; J Gliemann; R Jakes
Journal:  Biochem J       Date:  1997-04-15       Impact factor: 3.857

2.  Neurodegenerative diseases and transglutaminase.

Authors:  L Lorand
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-10       Impact factor: 11.205

3.  Saliency modulates global perception in simultanagnosia.

Authors:  Elisabeth Huberle; Hans-Otto Karnath
Journal:  Exp Brain Res       Date:  2010-07-01       Impact factor: 1.972

4.  Inhibition of amyloid-β plaque formation by α-synuclein.

Authors:  Teresa Bachhuber; Natalie Katzmarski; Joanna F McCarter; Desiree Loreth; Sabina Tahirovic; Frits Kamp; Claudia Abou-Ajram; Brigitte Nuscher; Alberto Serrano-Pozo; Alexandra Müller; Marco Prinz; Harald Steiner; Bradley T Hyman; Christian Haass; Melanie Meyer-Luehmann
Journal:  Nat Med       Date:  2015-06-22       Impact factor: 53.440

5.  Tissue transglutaminase-induced aggregation of alpha-synuclein: Implications for Lewy body formation in Parkinson's disease and dementia with Lewy bodies.

Authors:  Eunsung Junn; Ruben D Ronchetti; Martha M Quezado; Soo-Youl Kim; M Maral Mouradian
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-07       Impact factor: 11.205

6.  Tissue transglutaminase, protein cross-linking and Alzheimer's disease: review and views.

Authors:  Deng-Shun Wang; Dennis W Dickson; James S Malter
Journal:  Int J Clin Exp Pathol       Date:  2008-01-01

Review 7.  Transglutaminases and neurodegeneration.

Authors:  Thomas M Jeitner; John T Pinto; Boris F Krasnikov; Mark Horswill; Arthur J L Cooper
Journal:  J Neurochem       Date:  2009-05       Impact factor: 5.372

8.  Transglutaminase-mediated intramolecular cross-linking of membrane-bound alpha-synuclein promotes amyloid formation in Lewy bodies.

Authors:  Zoltán Nemes; Goran Petrovski; Maarten Aerts; Kjell Sergeant; Bart Devreese; László Fésüs
Journal:  J Biol Chem       Date:  2009-08-03       Impact factor: 5.157

9.  Tissue transglutaminase modulates alpha-synuclein oligomerization.

Authors:  Ine M J Segers-Nolten; Micha M M Wilhelmus; Gertjan Veldhuis; Bart D van Rooijen; Benjamin Drukarch; Vinod Subramaniam
Journal:  Protein Sci       Date:  2008-05-27       Impact factor: 6.725

10.  Development of a new treatment for Alzheimer's disease and Parkinson's disease using anti-aggregatory beta-synuclein-derived peptides.

Authors:  Manfred Windisch; Birgit Hutter-Paier; Edward Rockenstein; Makoto Hashimoto; Margaret Mallory; Eliezer Masliah
Journal:  J Mol Neurosci       Date:  2002 Aug-Oct       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.